Published in Oncotarget on July 11, 2017
Why do cancers have high aerobic glycolysis? Nat Rev Cancer (2004) 20.60
Hepatocellular carcinoma. N Engl J Med (2011) 19.40
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell (1988) 7.50
Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res (2006) 3.90
Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu Rev Biomed Eng (2008) 3.53
Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn Reson Med (2000) 3.46
Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res (2009) 3.40
Magnetic resonance imaging of glutamate. Nat Med (2012) 3.17
Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer (2011) 3.10
Acidity generated by the tumor microenvironment drives local invasion. Cancer Res (2013) 2.63
A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res (2009) 2.30
Fluorescence lifetime imaging system for in vivo studies. Mol Imaging (2007) 1.83
In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng (2005) 1.78
Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev (2007) 1.68
Imaging pH and metastasis. NMR Biomed (2011) 1.67
Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol (2003) 1.57
Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: In vivo studies in mice at 7 T. Magn Reson Med (2011) 1.57
Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI. Magn Reson Med (2013) 1.48
Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells. Oncogene (2001) 1.41
Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol (2003) 1.38
Clastogenicity of low pH to various cultured mammalian cells. Mutat Res (1992) 1.30
Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. J Natl Cancer Inst (2006) 1.17
Biological applications of spin pH probes. Cell Mol Biol (Noisy-le-grand) (2000) 1.15
Imaging the pH evolution of an acute kidney injury model by means of iopamidol, a MRI-CEST pH-responsive contrast agent. Magn Reson Med (2012) 1.14
A general MRI-CEST ratiometric approach for pH imaging: demonstration of in vivo pH mapping with iobitridol. J Am Chem Soc (2014) 1.12
Improved measurement of labile proton concentration-weighted chemical exchange rate (k(ws)) with experimental factor-compensated and T(1) -normalized quantitative chemical exchange saturation transfer (CEST) MRI. Contrast Media Mol Imaging (2012) 1.00
pH and chemotherapy. Novartis Found Symp (2001) 0.98
A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pH. Contrast Media Mol Imaging (2015) 0.93
Pilot study of Iopamidol-based quantitative pH imaging on a clinical 3T MR scanner. MAGMA (2014) 0.92
Label-free in vivo molecular imaging of underglycosylated mucin-1 expression in tumour cells. Nat Commun (2015) 0.91
Evaluation of the dependence of CEST-EPI measurement on repetition time, RF irradiation duty cycle and imaging flip angle for enhanced pH sensitivity. Phys Med Biol (2013) 0.91
Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy. Mol Cell (2015) 0.88
Quantitative description of radiofrequency (RF) power-based ratiometric chemical exchange saturation transfer (CEST) pH imaging. NMR Biomed (2015) 0.81
The pharmacokinetic profile, tolerability and safety of the iodinated, non-ionic, dimeric contrast medium Iosimenol 340 injection in healthy human subjects. Acta Radiol (2014) 0.79
In Vitro and In Vivo Assessment of Nonionic Iodinated Radiographic Molecules as Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Tumor Perfusion Agents. Invest Radiol (2016) 0.77
Comparison of allergic adverse effects and contrast enhancement between iodixanol and iopromide. Iran J Radiol (2012) 0.77
Magnetization transfer prepared gradient echo MRI for CEST imaging. PLoS One (2014) 0.77
Chemical Exchange Saturation Transfer (CEST) MR Technique for Liver Imaging at 3.0 Tesla: an Evaluation of Different Offset Number and an After-Meal and Over-Night-Fast Comparison. Mol Imaging Biol (2016) 0.77
Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib. Clin Cancer Res (2015) 0.76
Novel gradient echo sequence‑based amide proton transfer magnetic resonance imaging in hyperacute cerebral infarction. Mol Med Rep (2015) 0.75